May 22, 2018 / 7:47 AM / 3 months ago

BRIEF-India's Dr.Reddy's Labs March Qtr Consol Profit Down 3.3 Pct

May 22 (Reuters) - Dr.Reddy’s Laboratories Ltd:

* MARCH QUARTER NET PROFIT 3.02 BILLION RUPEES

* CONSENSUS FORECAST FOR MARCH QUARTER CONSOL PROFIT WAS 3.59 BILLION RUPEES

* RECOMMENDED FINAL DIVIDEND OF 20 RUPEES PER SHARE

* MARCH QUARTER CONSOL NET SALES 35.35 BILLION RUPEES VERSUS 35.54 BILLION RUPEES LAST YEAR

* MARCH QUARTER 2017 CONSOL NET PROFIT 3.13 BILLION RUPEES

* SAYS CONCLUDED A CHALLENGING YEAR FOR CO WTH A RELATIVELY MUTED Q4 PERFORMANCE

* PERFORMANCE IN QTR MAINLY ON ACCOUNT OF CONTINUING HEADWINDS IN U.S. MARKETS, TEMPORARY DROP IN SALES IN RUSSIA THE PROFIT ALERT WAS FIRST SOURCED FROM TV AND LATER CONFIRMED FROM A PRESS RELEASE ON THE BSE Source text - bit.ly/2wWWXlU Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below